MedTrace Logo

The Study of Breast MRI Screening and Proton Magnetic Resonance Spectroscopy

NCT01749748 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2016-02-02

No results posted yet for this study

Summary

To delineate if the chemical composition (lipid and water) in the presumably normal breast of the high risk women is different from those of the low risk group.

Conditions

  • Breast Diseases

Interventions

PROCEDURE

proton magnetic resonance spectroscopy

proton magnetic resonance spectroscopy was performed for the normal breast to evaluate the chemical composition of breast

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Jane Wang, PhD · National Taiwan University Hospital

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2015-08-31
Completion
2016-02-29

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01749748 on ClinicalTrials.gov